Non small cell lung cancer surgery

Jump to navigation Jump to search

Non Small Cell Lung Cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non Small Cell Lung Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Approach

Stage I
Stage II
Stage III
Stage IV
Metastatic Cancer

Medical Therapy

Chemotherapy
Radiation Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non small cell lung cancer surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non small cell lung cancer surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non small cell lung cancer surgery

CDC on Non small cell lung cancer surgery

Non small cell lung cancer surgery in the news

Blogs on Non small cell lung cancer surgery

Directions to Hospitals Treating Non small cell carcinoma of the lung

Risk calculators and risk factors for Non small cell lung cancer surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Surgery is the mainstay of therapy for early-stage non-small cell lung cancer. Common surgical procedures for the treatment of non-small cell lung cancer, include lung resection with lobectomy, lung resection with pneumonectomy with or without lymph node dissection. The preferred surgical procedure is thoracotomy with the removal of the entire lung or lobe (lobectomy) along with regional lymph nodes and contiguous structures.

Surgery

In non-small cell lung cancer, surgical procedure selection will depend on the histology, margins, and size of the tumor.[1][2]

  • Surgery is the mainstay of therapy for early-stage non-small cell lung cancer.
  • Common surgical procedures for the treatment of non-small cell lung cancer, include:
  • Lung resection with lobectomy
  • Lung resection with pneumonectomy with or without lymph node dissection
  • The preferred surgical procedure is thoracotomy with the removal of the entire lung or lobe (lobectomy) along with regional lymph nodes (peribronchial and perihilar lymph node dissection) and pathological evaluation.
  • If evidence of lymph node extension of the disease is present adjuvant chemotherapy should be administered.
  • Surgical resection is not recommended for patients with advanced or metastatic non-small cell lung carcinoma.
  • Surgical staging of the mediastinum is considered standard if accurate evaluation of the nodal status is needed to determine therapy.
  • Surgical treatment consists of a thoracotomy with removal of the entire lung or lobe along with regional lymph nodes and contiguous structures.
  • Pneumonectomy is used if the tumor involves the main bronchus, extends across a fissure or is located such that wide excision is required.
  • Survival following ‘curative’ resection is approximately 30% at 5 years and 15% at 10 years.
  • The best results are found in squamous cell carcinoma followed by large-cell carcinoma and the adenocarcinoma.
  • If the pathological evaluation of the dissected lymph nodes is positive to malignant neoplastic cells, the patient should be treated according to the Stage III treatment algorithm.
  • If the tumor is inoperable, stereotactic ablative radiation therapy should be administered.

Indications

Non-small cell lung cancer surgery is usually reserved for patients with the following characteristics:[1]

  • Pulmonary function testing
  • Preoperative assessment of FEV1/DLCO
  • FEV1 >2 L (or more than 80%)
  • DLCO > 80
  • Successful cutoff of 22 m on the stair climbing test
  • Fitness for surgery
  • Evaluation of risk factors, such as:
  • Age
  • General health status (obesity, Karnofsky scale >70)
  • COPD/asthma
  • Smoking
  • Other conditions: pulmonary hypertension, heart failure, and metabolic factors

Contraindications

Non small cell lung cancer surgery is usually contraindicated in patients with the following characteristics:[2]

  • Non-small cell lung cancer extension past the diaphragm
  • Involvement of contralateral hemithorax
  • Invasion of structures of the mediastinum

Complications

Common complications of non small cell lung cancer surgery, include:[2]

References

  1. 1.0 1.1 von Groote-Bidlingmaier F, Koegelenberg CF, Bolliger CT (2011). "Functional evaluation before lung resection". Clin. Chest Med. 32 (4): 773–82. doi:10.1016/j.ccm.2011.08.001. PMID 22054885.
  2. 2.0 2.1 2.2 Smetana GW, Lawrence VA, Cornell JE (2006). "Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians". Ann. Intern. Med. 144 (8): 581–95. PMID 16618956.


Template:WikiDoc Sources